Research by NSS Labs indicates that in its testing, Microsoft� (NASDAQ: MSFT ) �Internet Explorer and Google� (NASDAQ: GOOG ) �Chrome are the safest browsers.
NSS, which bills itself as "the world's leading information security research and advisory company," recenlty unveiled the results of its Browser Security Comparative Analysis: Socially Engineered Malware. Over the course of 28 days, from March 13 through April 9, the firm tested the five, most popular browsers against 754 samples of real-world malicious software. The browsers were�Apple� (NASDAQ: AAPL ) Safari 5,�Google�Chrome 25/26, Microsoft�Internet Explorer 10, Mozilla Firefox 19, and Opera 12.
The results revealed significant safety differences.
Blocking technologies used by browsers (higher is better).
Source: NSS-Browser Security Comparative Analysis
Top Defense Stocks To Own Right Now: Paulson Capital Corp.(PLCC)
Paulson Capital Corp., through its subsidiary, Paulson Investment Company, Inc., operates as a brokerage company principally in the United States. It engages in securities brokerage activities, which include acting as agent for purchase and sale of common and preferred stocks, options, warrants, and debt securities traded on securities exchanges or in the over-the-counter market. The company?s corporate finance activities comprise underwriting initial and follow-on public offerings, private investments in public equity, and private placements for smaller companies; securities trading and market making activities consist of executing trades in equity securities, corporate debt securities, and municipal bonds; and market making activities are conducted with dealers in the wholesale market and its customers. Its investment activities include holding securities for investment, which primarily include securities purchased for investment and underwriter warrants. As of December 31, 2010, the company operated 39 branch offices in California, Colorado, Connecticut, Florida, Georgia, New Jersey, New York, Oregon, Utah, and Washington. Paulson Capital Corp. was founded in 1969 and is based in Portland, Oregon.
Advisors' Opinion:- [By CRWE]
Paulson Capital Corp. (Nasdaq:PLCC), parent company of Paulson Investment Company, Inc., reported a net income of $1,412,294 (or $0.24 per share) for the three months ended March 31, 2012 versus a net loss of $381,210 (or ($0.07) per share) for the like period in 2011.
Top 5 Safest Stocks To Invest In Right Now: Threshold Pharmaceuticals Inc.(THLD)
Threshold Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of drugs targeting the microenvironment of solid tumors for patients living with cancer. The company?s products include TH-302, a novel drug candidate which is in Phase 1, Phase 1/2, and Phase 2 clinical trials for cancer. It has a license agreement with Eleison Pharmaceuticals, Inc. to develop and commercialize glufosfamide for the treatment of cancer in humans and animals. The company was founded in 2001 and is headquartered in Redwood City, California.
Advisors' Opinion:- [By James E. Brumley]
Stocks as a whole haven't gotten the new year off on the best foot, but that's not to say every equity out there is in trouble. Indeed, some small cap stocks may actually be doing well - and poised to do well for a while - specifically because larger companies are seeing their stocks struggle. To that end, traders looking for a bullish bright spot to start the new year may want to take a closer look at Amedica Corporation (NASDAQ:AMDA), Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), and Aethlon Medical, Inc. (OTCMKTS:AEMD).
Top 5 Safest Stocks To Invest In Right Now: Polydex Pharmaceuticals Ltd (POLXF.PK)
Polydex Pharmaceuticals Limited, incorporated on June 14, 1979, is engaged in the research, development, manufacture and marketing of biotechnology-based products for the human pharmaceutical market. The Company also manufactures bulk pharmaceutical intermediates for the global veterinary pharmaceutical industry. It focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The products of the Company include Iron Dextran and Dextran Sulphate. The wholly owned subsidiaries of the Company include Dextran Products Limited (Dextran Products) and Chemdex Inc (Chemdex).
Iron Dextran
Iron Dextran is a derivative of Dextran produced by complexing iron with Dextran. Iron Dextran is injected into pigs at birth as a treatment for anemia. The Company sells Iron Dextran to independent distributors and wholesalers in Europe, the Far East and Canada. Chemdex, Inc. has United States FDA approval for the manufacture and sale of Iron Dextran for veterinary use.
Dextran Sulphate
Dextran Sulphate is a specialty chemical derivative of Dextran used in research applications by the pharmaceutical industry and other centers of chemical research. Dextran Sulphate manufactured by the Company is sold primarily to independent distributors and wholesalers in the United States and Europe as analytical chemical applications.
Advisors' Opinion:- [By The GeoTeam]
Polydex Pharmaceuticals (POLXF.PK) Limited, through its subsidiaries, engages in the development, manufacture, and marketing of biotechnology-based products for the human pharmaceutical market. It is also involved with manufacture of bulk pharmaceutical intermediates for the veterinary pharmaceutical industry worldwide. It primarily offers Dextran and Dextran derivative products.
Top 5 Safest Stocks To Invest In Right Now: Check Point Software Technologies Ltd.(CHKP)
Check Point Software Technologies Ltd. develops, markets, and supports a range of software, and combined hardware and software products and services for information technology (IT) security applications worldwide. The company offers a range of network and gateway security solutions, data and endpoint security solutions, and management solutions. Its network security gateways enables its customers to implement their security policies on network traffic between internal networks and the Internet, as well as between internal networks and private networks that are shared with partners. The company?s endpoint security solutions provide various software blades that run on individual computers connected to the network, such as desktop computers, laptop computers, and other mobile devices. It also offers technical services consisting of technical customer support programs and plans, such as enterprise based support and collaborative enterprise support; certification and education al training on the checkpoint?s products; and professional services in implementing, upgrading, and optimizing checkpoint?s products, including design planning, security implementation, and project management services. In addition, the company offers ZoneAlarm solutions that protect consumers from hackers, spyware, and identity theft. It sells its products and services through a network of channel partners, including distributors, resellers, value-added resellers, system integrators, and managed services providers to enterprises, service providers, small and medium sized businesses, and consumers. The company was founded in 1993 and is headquartered in Tel Aviv, Israel.
Advisors' Opinion:- [By Monica Gerson]
Check Point Software Technologies (NASDAQ: CHKP) is projected to report its Q3 earnings at $0.84 per share on revenue of $343.62 million.
Hasbro (NASDAQ: HAS) is estimated to report its Q3 earnings at $1.29 per share on revenue of $1.34 billion.
No comments:
Post a Comment